Veeva Systems Inc.
NYSE:VEEVMedical - Healthcare Information Services
-$2.83 today
- Market cap
- $44.88B
- Beta
- 0.95
- P/E (TTM)
- 26.4
- EPS (TTM)
- $5.76
Volume 2.74M
Average 3.01M
VEEV Free Cash Flow
Operating cash flow minus capital expenditures: cash available for debt repayment, dividends, and buybacks.
Veeva Systems Inc.NYSE: VEEV
Free Cash Flow · Q2 FY2027 · quarter ended Jul 2026
Free cash flow dips below year-ago levels
Q2 FY2027 free cash flow of $230.69M fell 0.6% year over year, behind the +23.7% change in trailing-twelve-month free cash flow. Sequentially, it fell 79.5% from the prior quarter. Over 3 fiscal years it compounded at +21.8% a year.
Context
- Free cash flow amounted to 43.4% of revenue in FY2026, up 4.4 pp from a year earlier.
- Free cash flow increased in 3 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -0.6% toward the trailing-twelve-month pace of +23.7%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Free Cash Flow history
USD · from the cash flow
- Latest · FY2026
- 1.39B USD
- Year-over-year change
- +29.6%
- 4-year CAGR
- +16.6%
| Period | Period end | Free Cash Flow | YoY change |
|---|---|---|---|
| FY2026 | 2026-01-31 | 1.39B | +29.6% |
| FY2025 | 2025-01-31 | 1.07B | +20.8% |
| FY2024 | 2024-01-31 | 885.14M | +15.4% |
| FY2023 | 2023-01-31 | 766.96M | +2.2% |
| FY2022 | 2022-01-31 | 750.25M | — |
Free Cash Flow vs competitors
How VEEV compares with its peers on the latest reported figures
- VEEV's LTM Jul 2026 free cash flow of $1.64B is the 2nd largest of the 5 companies compared; the peer median is $180.5M.
- Its year-over-year change of +23.7% is the 3rd highest of 5, against a peer median of +19.0%.
- Free cash flow amounts to 47.5% of revenue for VEEV, versus a peer median of 31.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $2.61B | +30.0% | +8.9% | 15.4% | |
| LTM Jul 2026 | $1.64B | +23.7% | +21.8% | 47.5% | |
| LTM Sep 2026 | $301M | -3.6% | +22.3% | 45.5% | |
| LTM Sep 2026 | $116.77M | +3339.6% | — | 43.4% | |
| LTM Mar 2026 | $60.01M | +8.1% | +6.5% | 19.2% | |
| Peer median (excluding VEEV) | $180.5M | +19.0% | +8.9% | 31.3% | |
Competitors are the stored peer set for VEEV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Jan 2022 | FY2023 Jan 2023 | FY2024 Jan 2024 | FY2025 Jan 2025 | FY2026 Jan 2026 |
|---|---|---|---|---|---|
| Net Income | 427.39M | 487.71M | 525.71M | 714.14M | 908.91M |
| Depreciation & Amortization | 36.97M | 37.66M | 37.15M | 50.93M | 50.47M |
| Deferred Income Tax | 11.08M | (127.5M) | (105.37M) | (112.27M) | 65.09M |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 472.7M |
| Change in Working Capital | 20.66M | 7.34M | 60.82M | 7.62M | (91.94M) |
| Accounts Receivables | (83.08M) | (91.09M) | (104M) | (168.97M) | (254.55M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | (3M) | 21.43M | (10.23M) | (1.96M) | 6.08M |
| Other Working Capital | 106.74M | 77M | 175.05M | 178.55M | 156.53M |
| Other Non-Cash Items | 268.37M | 375.26M | 393.03M | 429.64M | 9.99M |
| Operating Cash Flow | 764.46M | 780.47M | 911.34M | 1.09B | 1.42B |
| Capital Expenditures | (14.21M) | (13.51M) | (26.2M) | (20.52M) | (29.13M) |
| Acquisitions (Net) | (7.78M) | 0 | 0 | 0 | 0 |
| Purchases of Investments | (1.12B) | (2B) | (2.7B) | (2.58B) | (3.13B) |
| Sales of Investments | 792.92M | 1B | 1.65B | 1.9B | 2.06B |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (346.15M) | (1.01B) | (1.08B) | (700.14M) | (1.1B) |
| Debt Repayment | (384K) | 0 | 0 | 0 | 0 |
| Common Stock Issued | 51.54M | 43.65M | 62.69M | 105.54M | 253.86M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | (169.95M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (55.29M) | (63.03M) | (78.88M) | (79.42M) | (93.25M) |
| Financing Cash Flow | (4.14M) | (19.38M) | (16.19M) | 26.12M | (9.33M) |
| Effect of Forex Changes | (4.66M) | (4.99M) | (1.78M) | (1.74M) | 919K |
| Net Change in Cash | 409.51M | (251.58M) | (182.98M) | 414.29M | 302.45M |
| Free Cash Flow | 750.25M | 766.96M | 885.14M | 1.07B | 1.39B |
Veeva Systems Inc.
NYSE:VEEV
Intrinsic Alpha fair value
Locked
Current Price
$277.20
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.